Re:Cognition Health is acknowledged as a leading UK independent provider of cognitive health services. We provide early, accurate, diagnosis and treatment of cognitive disorders affecting individuals, of all ages, suffering from cognitive impairment as a consequence of a wide range of clinical conditions. Re:Cognition Health’s clinical trials centres in London, Guildford and Plymouth, offer thos
e, who are clinically eligible, early access to new medications designed to slow down or halt progression of MCI, mild and moderate memory loss due to Alzheimer’s Disease
Our patients choose us because we are highly patient-centric, collaborative and effective, providing the most accurate diagnosis available and access to new and emerging treatments. Re:Cognition Health’s Birmingham centre is on schedule to open in summer 2017.